These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 174488)

  • 41. Phosphorylation within the amino-terminal acidic domain I of the phosphoprotein of vesicular stomatitis virus is required for transcription but not for replication.
    Pattnaik AK; Hwang L; Li T; Englund N; Mathur M; Das T; Banerjee AK
    J Virol; 1997 Nov; 71(11):8167-75. PubMed ID: 9343167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on the antiviral mechanisms of protein kinase inhibitors K-252a and KT5926 against the replication of vesicular stomatitis virus.
    Kim YS; Kawai A
    Biol Pharm Bull; 1998 May; 21(5):498-505. PubMed ID: 9635507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of in vitro transcription products of intracellular vesicular stomatitis virus RNA polymerase.
    Galet H; Hallett D; Prevec L
    J Virol; 1976 Aug; 19(2):467-74. PubMed ID: 183012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vesicular stomatitis viruses resistant to the methylase inhibitor sinefungin upregulate RNA synthesis and reveal mutations that affect mRNA cap methylation.
    Li J; Chorba JS; Whelan SP
    J Virol; 2007 Apr; 81(8):4104-15. PubMed ID: 17301155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The nature of the RNA products synthesized in vitro by subviral components of visicular stomatitis virus.
    Abraham G; Banerjee AK
    Virology; 1976 May; 71(1):230-41. PubMed ID: 179202
    [No Abstract]   [Full Text] [Related]  

  • 46. Two RNA polymerase complexes from vesicular stomatitis virus-infected cells that carry out transcription and replication of genome RNA.
    Qanungo KR; Shaji D; Mathur M; Banerjee AK
    Proc Natl Acad Sci U S A; 2004 Apr; 101(16):5952-7. PubMed ID: 15069200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotide.
    Prasad V; Hashim S; Mukhopadhyay A; Basu SK; Roy RP
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2689-96. PubMed ID: 10543748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potentiation of the antiviral activity of interferon by actinomycin D.
    Chany C; Fournier F; Rousset S
    Nat New Biol; 1971 Mar; 230(12):113-4. PubMed ID: 4323631
    [No Abstract]   [Full Text] [Related]  

  • 49. Mode of action of acid pH values on the development of vesicular stomatitis virus.
    Fiszman M; Leaute JB; Chany C; Girard M
    J Virol; 1974 Apr; 13(4):801-8. PubMed ID: 4132389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of RNA virus replication in vitro by 3-deazacytidine and 3-deazauridine.
    Khare GP; Sidwell RW; Huffman JH; Tolman RL; Robins RK
    Proc Soc Exp Biol Med; 1972 Jul; 140(3):880-4. PubMed ID: 4339065
    [No Abstract]   [Full Text] [Related]  

  • 51. Constitutive phosphorylation of the vesicular stomatitis virus P protein modulates polymerase complex formation but is not essential for transcription or replication.
    Spadafora D; Canter DM; Jackson RL; Perrault J
    J Virol; 1996 Jul; 70(7):4538-48. PubMed ID: 8676480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolation of an infectious ribonucleoprotein from vesicular stomatitis virus containing an active RNA transcriptase.
    Szilágyi JF; Uryvayev L
    J Virol; 1973 Feb; 11(2):279-86. PubMed ID: 4347429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vesicular stomatitis virion-associated transcriptase activity was suppressed in vitro by a synthetic 21 amino acid oligopeptide prepared to mimic the carboxy-terminus of NS protein.
    Yamashita T; Kawai A
    Virology; 1990 Sep; 178(1):166-73. PubMed ID: 2167548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purification of defective interfering T particles of vesicular stomatitis and rabies viruses generated in vivo in brains of newborn mice.
    Holland JJ; Villarreal LP
    Virology; 1975 Oct; 67(2):438-49. PubMed ID: 171834
    [No Abstract]   [Full Text] [Related]  

  • 55. Redistributive properties of the vesicular stomatitis virus polymerase.
    Helfman WB; Perrault J
    Virology; 1989 Aug; 171(2):319-30. PubMed ID: 2548323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The tdCE and hrCE phenotypes: host range mutants of vesicular stomatitis virus in which polymerase function is affected.
    Pringle CR
    Cell; 1978 Oct; 15(2):597-606. PubMed ID: 214246
    [No Abstract]   [Full Text] [Related]  

  • 57. Vesicular stomatitis virus infection reduces the number of active DNA-dependent RNA polymerases in myeloma cells.
    Weck PK; Wagner RR
    J Biol Chem; 1979 Jun; 254(12):5430-4. PubMed ID: 221470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies on the in vivo and in vitro messenger RNA species of vesicular stomatitis virus.
    Moyer SA; Grubman MJ; Ehrenfeld E; Banerjee AK
    Virology; 1975 Oct; 67(2):463-73. PubMed ID: 171836
    [No Abstract]   [Full Text] [Related]  

  • 59. Protamine--a potent inhibitor of vesicular stomatitis virus transcriptase in vitro.
    Talib S; Banerjee AK
    Biochem Biophys Res Commun; 1981 Feb; 98(3):875-83. PubMed ID: 6261754
    [No Abstract]   [Full Text] [Related]  

  • 60. Heterogeneity of the sensitivity of vesicular stomatitis virus to interferons.
    Ito Y; Montagnier L
    Infect Immun; 1977 Oct; 18(1):23-7. PubMed ID: 198374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.